The Prevention Paradox
The Prevention Paradox: Glaucoma treatment asks patients, physicians, and payers to act before the consequences are visible.
-
By
-
Nathan Radcliffe, MD
-
September 1, 2026
-
Clinical Scorecard: The Prevention Paradox
At a Glance
| Category | Detail |
|---|
| Condition | Glaucoma |
| Key Mechanisms | Prevention of vision loss through early intervention and ongoing treatment. |
| Target Population | Patients at risk of glaucoma and vision loss. |
| Care Setting | Ophthalmology clinics and surgical centers. |
Key Highlights
- Glaucoma treatment requires long-term patient adherence to therapy.
- Successful treatment often means preventing deterioration rather than improving vision.
- Economic benefits of prevention are often delayed and not immediately visible.
- Insurance policies can hinder access to necessary glaucoma treatments.
- Advocacy for patient access to treatments is essential.
Guideline-Based Recommendations
Diagnosis
- Regular eye examinations for early detection of glaucoma.
Management
- Use of topical medications, laser therapy, and surgical interventions.
Monitoring & Follow-up
- Frequent follow-up visits to assess intraocular pressure and treatment efficacy.
Risks
- Potential vision loss if treatment is not adhered to.
Patient & Prescribing Data
Individuals diagnosed with or at risk for glaucoma.
Long-term adherence to prescribed therapies is crucial for preserving vision.
Clinical Best Practices
- Engage patients in discussions about the importance of ongoing treatment.
- Educate patients about the long-term nature of glaucoma management.
- Advocate for policies that support access to glaucoma treatments.
Related Resources & Content
